Last Update 22 Jul 26
Fair value Increased 8.23%IQE: Multi Year Supply Deals Will Define The Next Phase
The analyst price target for IQE has been raised to £0.61 from £0.57, with analysts citing updated fair value assumptions, revised revenue growth expectations and recent research highlighting strong demand in several key end markets.
Analyst Commentary
Recent Street research on IQE highlights both optimism around demand in its core markets and questions about whether the current share price already reflects these expectations. Readers weighing the raised price targets against their own assumptions on execution, margins and capital needs may want to focus on how these views translate into risk and reward.
Bullish Takeaways
- Bullish analysts point to the 50 GBp and 60 GBp price targets as support for upside potential relative to recent trading levels, assuming IQE can deliver on its updated revenue expectations.
- Recent commentary cites very strong demand for several of IQE's products, which bullish analysts see as a foundation for scaling volumes and potentially improving operating leverage over time.
- The view that several end markets are described as booming feeds into more constructive assumptions around utilisation, which supports higher fair value estimates in discounted cash flow and relative valuation work.
- The re-initiation of coverage following a strategic review is taken by bullish analysts as a sign that IQE's medium term positioning in its target markets is clearer, which they factor into higher conviction on execution.
Bearish Takeaways
- Bearish analysts may question whether price targets in the 50 to 60 GBp range already assume favourable outcomes on demand and capacity, leaving less room for error if market conditions or customer orders soften.
- Stronger demand expectations can raise concerns about IQE's ability to execute on any required capacity expansions without pressuring returns, particularly if capital spending or working capital needs increase.
- Where end markets are described as booming, more cautious analysts may worry that IQE's current valuation could be exposed if these conditions normalise or if customers adjust inventory levels.
- The reliance on a constructive post review outlook may be seen as a risk if there is limited evidence yet on how any changes in IQE's focus or cost structure will translate into consistent revenue and margin delivery.
What's in the News for IQE
- IQE issued earnings guidance for Fiscal Year 2026 indicating expected revenue growth in excess of 30% year on year. (Source: Company guidance)
- The company announced a multi year production order valued at US$14,000,000 from a strategic global technology customer, with manufacturing at IQE's Newport foundry to support AI and datacentre applications. (Source: Client announcement)
- IQE entered a multi year Indium Phosphide epiwafer supply agreement for AI driven data centre optical connectivity with Tower Semiconductor, which includes minimum purchase and volume commitments and a worldwide royalty free porous silicon patent license to IQE that settles prior litigation. (Source: Client announcement)
- MACOM Technology Solutions plans to enter Long Term Supply Agreements with IQE for epitaxial services across multiple technologies to support MACOM's growth plans. (Source: Client announcement)
- IQE completed follow on equity offerings totaling £13,000,000 at £0.198 per Ordinary Share, alongside a Special Shareholders Meeting to approve authorities for further share issuances connected to a proposed fundraising. (Source: Equity offering and shareholder meeting filings)
Valuation Changes for IQE
- Fair value has been revised from £0.57 to £0.61 per share, indicating a modest uplift in the central valuation estimate for IQE.
- The discount rate has been adjusted slightly from 12.75% to 12.85%, implying a marginally higher required return applied to IQE's cash flow forecasts.
- Revenue growth has been updated from 17.78% to 22.21%, reflecting higher assumptions for IQE's future top line expansion.
- The net profit margin has been reduced from 4.84% to 4.28%, indicating a more cautious view on IQE's future profitability per £ of revenue.
- The future P/E has moved from 106.25x to 116.90x, suggesting a higher earnings multiple being applied to IQE in the updated analysis.
Catalysts
About IQE
IQE supplies compound semiconductor epitaxy wafers that sit early in the chip supply chain for applications spanning AI, data centers, wireless, aerospace and defense, power and display.
What are the underlying business or industry changes driving this perspective?
- Rising AI compute and hyperscale data center build outs are driving higher demand for indium phosphide and GaN photonics. These can support higher wafer volumes on largely existing tools and may lift revenue and EBITDA margins as utilization improves.
- Growing focus on secure and resilient semiconductor supply chains by governments in the U.S., Europe and Asia aligns with IQE’s multi continent footprint. This can support more long-term customer agreements and may improve revenue visibility and earnings stability.
- Increased use of compound semiconductors where silicon is reaching performance limits, across areas such as high speed connectivity, power and sensing, supports broader uptake of IQE’s material systems. This may help mix shift towards higher margin products over time.
- Expanding opportunities in aerospace, defense and space related applications, supported by existing relationships and funding releases, create potential for higher value, longer duration programs that can support net margin resilience through cycles.
- Emerging microLED, AR/VR and advanced sensing programs with key customers, even from a low base today, offer optionality for new product ramps. These could add incremental revenue streams and improve overall earnings leverage on the current fixed cost base.
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming IQE's revenue will grow by 22.2% annually over the next 3 years.
- Analysts assume that profit margins will increase from -37.7% today to 4.3% in 3 years time.
- Analysts expect earnings to reach £7.6 million (and earnings per share of £0.01) by about July 2029, up from -£36.7 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting £20.0 million in earnings, and the most bearish expecting £-131.1 thousand.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 117.0x on those 2029 earnings, up from -12.6x today. This future PE is greater than the current PE for the GB Semiconductor industry at 4.4x.
- Analysts expect the number of shares outstanding to grow by 0.99% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 12.85%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?
- The wireless business remains exposed to swings in smartphone demand and customer inventory cycles, as shown by Wireless revenue of £40.1 million that was 40% lower in 2025. A repeat of this kind of volatility could put pressure on group revenue and dilute the benefit from stronger areas such as Photonics.
- The model relies heavily on higher volumes to absorb a large fixed cost base, with adjusted EBITDA of £3.2 million described as a reflection of low utilization. If AI, data center or defense demand grows more slowly than expected, margins and earnings could remain subdued despite the enhanced capacity.
- Customer and supplier concentration risks are embedded in the setup, with long term agreements and the £81 million fund raise tied in part to MACOM and indium phosphide supply described as a very sought after commodity. Any disruption in these relationships or material shortages could affect revenue visibility, net margins and cash flows.
- Growth in newer areas such as microLED, advanced sensing and GaN power is framed as a future opportunity rather than a current earnings engine. If these programs take longer to reach meaningful scale, the expected mix shift toward higher value products could be delayed, limiting margin expansion and earnings growth.
- The company has moved to a cleaner balance sheet with bank debt expected to be repaid and adjusted net debt of £31.5 million at year end 2025. However, future capacity expansions are tied to customer co funding or additional capital, so if external funding is harder to secure or customer commitments soften, this could constrain investment and slow revenue and earnings progression.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of £0.61 for IQE based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £0.7, and the most bearish reporting a price target of just £0.54.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £177.6 million, earnings will come to £7.6 million, and it would be trading on a PE ratio of 117.0x, assuming you use a discount rate of 12.8%.
- Given the current share price of £0.47, the analyst price target of £0.61 is 23.2% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on IQE?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.